How effective is Cogentin for Parkinson's Disease? (a real world drug study)
Summary:
Overall ratings: 2.3/5 Long term ratings: 2.3/5
This is a phase IV clinical study of how effective Cogentin (benztropine mesylate) is for Parkinson's disease and for what kind of people. The study is created by eHealthMe from 7 Cogentin users and is updated continuously.
What is Cogentin?
Cogentin has active ingredients of benztropine mesylate. It is often used in tardive dyskinesia. eHealthMe is studying from 7,692 Cogentin users. Check the latest studies of Cogentin.
What is Parkinson's disease?
Parkinson's disease is found to be associated with 1,116 drugs and 1,625 conditions by eHealthMe. Check the latest studies of Parkinson's disease.
7 people are studied for taking Cogentin in Parkinson's disease
Overall effectiveness (number of people):
Long term (1+ years) effectiveness (number of people):
Cogentin effectiveness for Parkinson's disease (number of people):
Overall:
- not at all: 1
- somewhat: 3
- moderate: 3
- high: 0
- very high: 0
Long Term:
- not at all: 0
- somewhat: 2
- moderate: 1
- high: 0
- very high: 0
Gender of people who take Cogentin for Parkinson's disease *:
- female: 57.14 %
- male: 42.86 %
Age of people who take Cogentin for Parkinson's disease *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 14.29 %
- 30-39: 28.57 %
- 40-49: 0.0 %
- 50-59: 14.29 %
- 60+: 42.86 %
Who find Cogentin more effective for Parkinson's Disease?
* Approximation only. Some reports may have incomplete information.
Do you take Cogentin?
- You can start a phase IV clinical trial to monitor Cogentin safety and effectiveness.How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related publications that referenced our studies:
- Woulfe JM, Gray MT, Gray DA, Munoz DG, Middeldorp JM, "Hypothesis: a role for EBV-induced molecular mimicry in Parkinson's disease", Parkinsonism & related disorders, 2014 Jul .
- Woulfe JM, Gray MT, Gray DA, Munoz DG, Middeldorp JM, "Hypothesis: a role for EBV-induced molecular mimicry in Parkinson's disease", Parkinsonism & related disorders, 2014 Jul .
Related studies
Alternative drugs to, pros and cons of:
- Cogentin (7,692 reports)
Treatments, associated drugs and conditions:
- Parkinson's disease (151,258 reports)
How the study uses the data?
The study is based on benztropine mesylate (the active ingredients of Cogentin) and Cogentin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study neither.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Behcet'S Syndrome and Blood Bilirubin Increased - 10 seconds ago
- Could Breo Ellipta cause Renal Neoplasm? - 18 seconds ago
- Drug interactions of Zoloft and Flovent Hfa - 24 seconds ago
- Could Copaxone cause Ovarian Cysts? - 32 seconds ago
- Could Carbamazepine cause Hyponatremia? - 33 seconds ago
- Drug interactions of Diamox and Trusopt - 40 seconds ago
- Could Valsartan cause Multiple Sclerosis Aggravated? - 44 seconds ago
- Could Tolterodine Tartrate cause Musculoskeletal Stiffness? - 45 seconds ago
- Could Valium cause Vaginal Bleeding Between Periods? - 51 seconds ago
- Could Temazepam cause Acute Psychosis? - 53 seconds ago